Head-to-head · WeighScore
PlushCare vs Vital Harmony Rx
The verdict
PlushCare takes it — 74.5/100 to 51.7/100.
PlushCare grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Established virtual primary-care telehealth platform (subsidiary of Transcarent, Inc., a Delaware corporation, alongside Accolade, 2nd.MD, and 98point6 by Transcarent).
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | PlushCare | Vital Harmony Rx |
|---|---|---|
| WeighScore | 74.5/100 | 51.7/100 |
| Grade | C | C |
| Scorecard rank | #63 | #484 |
| Semaglutide | $149/mo (starting dose, compounded) | Not disclosed |
| Tirzepatide | $399/mo (starting dose, compounded) | Not disclosed |
| Coverage | All 50 states | Coverage not published |
| Brand-name access | Yes | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #63 · C
Strengths
- Available in all 50 states
- Appointments with US board-certified physicians, not nurse practitioners only
- Virtual primary care — the same doctor can manage GLP-1s alongside other health needs
- Owned by Transcarent, a venture-backed health platform with a named corporate parent
Where it loses points
- Facing a California class action alleging deceptive subscription enrollment and unauthorized charges after cancellation
- GLP-1 prescribing is up to the clinician at the visit — not guaranteed at signup
- BBB complaints center on the membership cancellation process
Graded #484 · C
Strengths
- Verified LegitScript certification (ID 49230211) — a trust signal many compounded-GLP-1 DTC brands lack
- Explicit compounded-medication + 'not a pharmacy/manufacturer' disclosure on-site
- Both a semaglutide (GLP-1+B12) and a tirzepatide (GLP-1/GIP+B12) option
- Operates on a named physician network (Beluga Health)
Where it loses points
- NO pricing published anywhere on the site — a major gap for a cost-comparison directory; buyers cannot evaluate value without contacting the company
- No specific state list (only 'entire country' claimed)
- No named compounding pharmacy partner
- No named medical director / PIC, no legal entity or governing law disclosed
- Molecule strengths/dose tiers not published
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.